Mirae Asset Global Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.7M Buy
195,986
+56,424
+40% +$8.46M 0.05% 232
2026
Q1
$21.3M Sell
139,562
-202,974
-59% -$31.1M 0.01% 257
2025
Q4
$47.2M Sell
342,536
-56,622
-14% -$7.41M 0.13% 132
2025
Q3
$51.2M Sell
399,158
-3,202
-0.8% -$391K 0.16% 112
2025
Q2
$48.7M Sell
402,360
-25,558
-6% -$2.88M 0.17% 107
2025
Q1
$47.9M Sell
427,918
-100,764
-19% -$10.7M 0.2% 98
2024
Q4
$51.6M Buy
528,682
+296,890
+128% +$31.7M 0.21% 86
2024
Q3
$26.8M Buy
231,792
+124,111
+115% +$14.1M 0.12% 139
2024
Q2
$11.5M Buy
107,681
+24,954
+30% +$2.5M 0.06% 225
2024
Q1
$8M Buy
82,727
+26,632
+47% +$2.73M 0.02% 723
2023
Q4
$5.66M Sell
56,095
-2,410
-4% -$233K 0.01% 853
2023
Q3
$5.65M Hold
58,505
0.01% 828
2023
Q2
$5.9M Buy
58,505
+30,301
+107% +$3.03M 0.01% 845
2023
Q1
$2.59M Sell
28,204
-23,097
-45% -$2.02M 0.01% 1077
2022
Q4
$4.65M Sell
51,301
-10,531
-17% -$887K 0.01% 848
2022
Q3
$4.7M Sell
61,832
-69,171
-53% -$5.73M 0.01% 821
2022
Q2
$11.1M Sell
131,003
-3,656
-3% -$321K 0.03% 572
2022
Q1
$11.8M Sell
134,659
-7,686
-5% -$665K 0.02% 623
2021
Q4
$12.5M Sell
142,345
-4,060
-3% -$337K 0.03% 611
2021
Q3
$12M Sell
146,405
-222
-0.2% -$20K 0.03% 572
2021
Q2
$13.4M Sell
146,627
-205
-0.1% -$18.3K 0.04% 526
2021
Q1
$12.6M Sell
146,832
-183
-0.1% -$16.4K 0.04% 470
2020
Q4
$13.9M Buy
147,015
+39,760
+37% +$3.47M 0.05% 401
2020
Q3
$9.33M Sell
107,255
-24,362
-19% -$2.11M 0.05% 404
2020
Q2
$11.5M Sell
131,617
-7,421
-5% -$641K 0.07% 305
2020
Q1
$11.5M Sell
139,038
-1,950
-1% -$174K 0.09% 243
2019
Q4
$13.3M Buy
140,988
+18,783
+15% +$1.69M 0.08% 284
2019
Q3
$10.6M Sell
122,205
-4,453
-4% -$400K 0.07% 296
2019
Q2
$11.6M Buy
126,658
+24,138
+24% +$2.04M 0.08% 271
2019
Q1
$7.77M Sell
102,520
-44,454
-30% -$3.57M 0.06% 316
2018
Q4
$11.3M Buy
146,974
+26,549
+22% +$2.07M 0.1% 213
2018
Q3
$9.3M Buy
120,425
+33,733
+39% +$2.49M 0.07% 283
2018
Q2
$5.87M Sell
86,692
-104
-0.1% -$7.18K 0.08% 158
2018
Q1
$6.29M Buy
86,796
+2,765
+3% +$210K 0.08% 155
2017
Q4
$6.32M Buy
84,031
+12,240
+17% +$924K 0.08% 162
2017
Q3
$5.52M Buy
71,791
+10,305
+17% +$778K 0.1% 155
2017
Q2
$4.6M Sell
61,486
-11,798
-16% -$836K 0.08% 164
2017
Q1
$4.88M Buy
73,284
+20,501
+39% +$1.37M 0.09% 143
2016
Q4
$3.44M Sell
52,783
-7,448
-12% -$483K 0.08% 179
2016
Q3
$4.26M Buy
60,231
+42,352
+237% +$3.09M 0.09% 158
2016
Q2
$1.32M Sell
17,879
-6,361
-26% -$439K 0.03% 279
2016
Q1
$1.57M Sell
24,240
-34,972
-59% -$2.38M 0.04% 251
2015
Q4
$4.57M Buy
59,212
+4,919
+9% +$391K 0.15% 132
2015
Q3
$4.47M Sell
54,293
-2,400
-4% -$214K 0.18% 115
2015
Q2
$5M Buy
56,693
+558
+1% +$51.2K 0.16% 111
2015
Q1
$4.96M Buy
56,135
+3,136
+6% +$278K 0.17% 102
2014
Q4
$4.4M Buy
52,999
+9,475
+22% +$785K 0.16% 94
2014
Q3
$3.67M Buy
43,524
+5,915
+16% +$479K 0.13% 98
2014
Q2
$3.05M Buy
37,609
+1,785
+5% +$140K 0.07% 109
2014
Q1
$2.73M Buy
35,824
+20,758
+138% +$1.51M 0.07% 107
2013
Q4
$1.08M Hold
15,066
0.05% 267
2013
Q3
$1.04M Hold
15,066
0.05% 250
2013
Q2
$955K Buy
+15,066
New +$980K 0.05% 247

Other funds holding NVS

Mirae Asset Global Investments's NVS Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Novartis (NVS) stake by 40% in Q2 2026, buying an estimated $8.46M and bringing the position to 195,986 shares worth $30.7M. The position accounts for 0.05% of the portfolio, ranked #232.

Mirae Asset Global Investments first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $51.6M in Q4 2024. 772 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Mirae Asset Global Investments held 195,986 shares of Novartis worth $30.7M as of Q2 2026.
  • Mirae Asset Global Investments bought 56,424 Novartis shares in Q2 2026, an estimated $8.46M.
  • Novartis made up 0.05% of Mirae Asset Global Investments's portfolio in Q2 2026, its #232 holding.
  • Mirae Asset Global Investments first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Mirae Asset Global Investments's Novartis position peaked at $51.6M in Q4 2024.
  • 772 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.